{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:57:19Z","timestamp":1781974639791,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1888,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/jto.0b013e3181f21129","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T11:29:35Z","timestamp":1285068575000},"page":"S357-S360","source":"Crossref","is-referenced-by-count":45,"special_numbering":"S4","title":["The Role of Chemotherapy in Advanced Thymoma"],"prefix":"10.1016","volume":"5","author":[{"given":"Jordan","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Sr.","given":"Patrick J.","family":"Loehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181f21129_bib1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/1097-0142(196509)18:9<1131::AID-CNCR2820180914>3.0.CO;2-F","article-title":"Pathology and clinical behavior of thymomas: a survey of 51 cases","volume":"18","author":"Legg","year":"1965","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181f21129_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1097-0142(197408)34:2<389::AID-CNCR2820340224>3.0.CO;2-Z","article-title":"Thymomas: clinicopathologic features, therapy, and prognosis","volume":"34","author":"Batata","year":"1974","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181f21129_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1097-0142(19860801)58:3<765::AID-CNCR2820580326>3.0.CO;2-S","article-title":"Thymomas. A review of 169 cases with particular reference to results of surgical treatment","volume":"58","author":"Maggi","year":"1986","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181f21129_bib4","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/1097-0142(19871201)60:11<2727::AID-CNCR2820601125>3.0.CO;2-D","article-title":"Thymoma. A clinicopathologic review","volume":"60","author":"Lewis","year":"1987","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181f21129_bib5","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181f21129_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/1097-0142(19810715)48:2<223::AID-CNCR2820480202>3.0.CO;2-0","article-title":"Malignant thymoma: renal metastases responding to cis-platinum","volume":"48","author":"Needles","year":"1981","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181f21129_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000421-199308000-00014","article-title":"EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma","volume":"16","author":"Bonomi","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib8","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1200\/JCO.1999.17.9.2737","article-title":"Treatment of invasive thymoma with single-agent ifosfamide","volume":"17","author":"Highley","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib9","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/0140-6736(90)91415-7","article-title":"Effective interleukin-2 in invasive lymphepithelial thymoma","volume":"335","author":"Berthaud","year":"1990","journal-title":"Lancet"},{"key":"10.1097\/JTO.0b013e3181f21129_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00002371-199510000-00005","article-title":"A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed\/refractory thymoma","volume":"18","author":"Gordon","year":"1995","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199701233360405","article-title":"Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone","volume":"336","author":"Palmieri","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181f21129_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group phase II trial","volume":"22","author":"Loehrer","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib13","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1200\/JCO.1999.17.7.2280","article-title":"Thymoma: state of the art","volume":"17","author":"Thomas","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib14","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2005.03.115","article-title":"Dramatic responses to therapy in rare tumors","volume":"23","author":"Tiseo","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/jjco\/hyf059","article-title":"A case of recurrent metastatic thymoma showing a marked response to paclitaxel monotherapy","volume":"32","author":"Umemura","year":"2002","journal-title":"Jpn J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/1097-0142(19860315)57:6<1101::AID-CNCR2820570606>3.0.CO;2-A","article-title":"Chemotherapy of malignant thymoma: case report and review of the literature","volume":"57","author":"Hu","year":"1986","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181f21129_bib17","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181f21129_bib18","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib19","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","article-title":"Cisplatin, doxorubicin and cyclophosphamide plus thoracic radiation therapy for limited stage, unresectable thymoma: an intergroup trial","volume":"15","author":"Loehrer","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report","volume":"44","author":"Kim","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e3181f21129_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","article-title":"Chemotherapy for invasive thymoma: a 13 year experience","volume":"68","author":"Fornasiero","year":"1991","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181f21129_bib22","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Groups","volume":"14","author":"Giaccone","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib23","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/jco.2008.26.15_suppl.8018","article-title":"A phase II study of carboplatin plus paclitaxel in advanced thymoma or thymic carcinoma: E1C99","volume":"26","author":"Lemma","year":"2008","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib24","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1378\/chest.122.6.2249","article-title":"Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood stem cell transplantation for invasive thymoma","volume":"122","author":"Iwasaki","year":"2002","journal-title":"Chest"},{"key":"10.1097\/JTO.0b013e3181f21129_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF00273421","article-title":"Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies","volume":"22","author":"Gaspard","year":"1988","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.bmt.1703181","article-title":"High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience","volume":"28","author":"Hanna","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1097\/JTO.0b013e3181f21129_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-129-2-199807150-00006","article-title":"A multidisciplinary approach to therapy for unresectable malignant thymoma","volume":"129","author":"Shin","year":"1998","journal-title":"Ann Int Med"},{"key":"10.1097\/JTO.0b013e3181f21129_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/oxfordjournals.annonc.a058527","article-title":"Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymoma: Results in six patients","volume":"4","author":"Berruti","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e3181f21129_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5223(19)34092-9","article-title":"Chemotherapy and operation for invasive thymoma","volume":"106","author":"Rea","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0b013e3181f21129_bib30","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/1097-0142(19910815)68:4<706::AID-CNCR2820680407>3.0.CO;2-H","article-title":"Neoadjuvant chemotherapy, surgery and postoperative radiation therapy for invasive thymoma","volume":"68","author":"Macchiarini","year":"1991","journal-title":"Cancer"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415326307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415326307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:39:30Z","timestamp":1591922370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415326307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1556086415326307"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181f21129","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}